Clearance and Persistence of SARS-CoV-2 RNA in COVID-19 patients

Viral Infections, Non-HIV

Absence of SARS-CoV-2 in Semen of a COVID-19 Patient Cohort

Andrology.

Guo L, Zhao S, Li W, Wang Y, Li L, Jiang S, Ren W, Yuan Q, Zhang F, Kong F, Lei J, Yuan M

doi: 10.1111/andr.12848.

Viral Infections, Non-HIV

Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19?

J Med Virol.

Güemes-Villahoz N, Burgos-Blasco B, Vilela AA, Arriola-Villalobos P, Luna CMR, Sardiña RC, Delgado-Iribarren A, García-Feijoó J

doi: 10.1002/jmv.26219.

Viral Infections, Non-HIV

Abdominal Surgery in Patients with COVID-19: Detection of SARS-CoV-2 in Abdominal and Adipose Tissues

Ann Surg.

Safari S, Keyvani H, Alamdari NM, Dehghanian A, Hashemi MR, Honar BN, Aminian A

doi: 10.1097/SLA.0000000000004165.

Viral Infections, Non-HIV

Negative SARS-CoV-2 antibody testing following COVID-19 infection in Two MS patients treated with ocrelizumab

Mult Scler Relat Disord.

Thornton JR, Harel A

doi: 10.1016/j.msard.2020.102341.

Viral Infections, Non-HIV

Positive SARS-CoV-2 RNA recurs repeatedly in a case recovered from COVID-19: dynamic results from 108 days of follow-up

Pathog Dis.

Liu F, Cai ZB, Huang JS, Yu WY, Niu HY, Zhang Y, Sui DM, Wang F, Xue LZ, Xu AF

doi: 10.1093/femspd/ftaa031.

Viral Infections, Non-HIV

Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients

Clin Infect Dis.

Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, Men D, Huang Q, Liu Y, Yang B, Ding J, Li F

doi: 10.1093/cid/ciaa449.

Viral Infections, Non-HIV

Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19

J Med Virol.

Li TZ, Cao ZH, Chen Y, Cai MT, Zhang LY, Xu H, Zhang JY, Ma CH, Liu Y, Gao LJ, Duan ZH, Mou DL, Liang LC

doi: 10.1002/jmv.26280.

Viral Infections, Non-HIV

Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London

Clin Infect Dis.

Zhou J, Otter JA, Price JR, Cimpeanu C, Garcia DM, Kinross J, Boshier PR, Mason S, Bolt F, Holmes AH, Barclay WS

doi: 10.1093/cid/ciaa905.

Viral Infections, Non-HIV

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

Viruses.

Ahmed SF, Quadeer AA, McKay MR

doi: 10.3390/v12030254.

Related content

Absence of SARS-CoV-2 in Semen of a COVID-19 Patient Cohort

Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19?

Abdominal Surgery in Patients with COVID-19: Detection of SARS-CoV-2 in Abdominal and Adipose Tissues

Negative SARS-CoV-2 antibody testing following COVID-19 infection in Two MS patients treated with ocrelizumab

Positive SARS-CoV-2 RNA recurs repeatedly in a case recovered from COVID-19: dynamic results from 108 days of follow-up

Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients

Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19

Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies